BPC 157 and gut-liver-brain healing: Emerging clinical targets
Niacin or Nicotinamide riboside (what NAD+ is made of)
Sohmiya M, Tanaka M, Tak NW, Yanagisawa M, Tanino Y, Suzuki Y, Okamoto K, Yamamoto Y (2004) Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinsons disease
Excess free radicals are generated during detoxification and ME-3s ability to increase total antioxidant activity (TAA) means it will help protect the liver. 6) Balancing inflammation: Lactobacillus fermentum ME-3 has been shown to reduce levels of several key pro-inflammatory markers such as high sensitivity C-reactive protein (hs-CRP) and interleukin 6 (IL-6), and it is also capable of stimulating production of the peptide adiponectin and of reducing levels of glycated hemoglobin or HbA1c. Since inflammation has been shown to be a major contributing factor in most of todays chronic degenerative diseases, a substance that balances levels of inflammation can be a substance that helps to improve overall health

The extensive preclinical research documenting the mechanisms, effects, and safety profiles of GHK-Cu, BPC-157, and TB-500 establishes a robust scientific foundation for their combined use in laboratory applications, while ongoing research into peptide combinations, advanced delivery systems, and tissue engineering applications continues to expand potential investigational contexts
el Etreby, M